Pharmaceutical industry Sumitomo Dainippon seeks US startups with potential drugs – Nikkei Asian Review

Pharmaceutical industry Sumitomo Dainippon seeks US startups with potential drugs
Nikkei Asian Review
The drugmaker generates nearly 60% of its revenue outside Japan, thanks in part to efforts to bolster its presence in the U.S., the world’s biggest pharmaceutical market. There, Sumitomo Dainippon acquired Sepracor in 2009 for roughly 230 billion yen

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd